trial · primary record
Panzyga, 10% Intravenous Solution
Hypogammaglobulinemia
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 360 |
| Primary completion | 2029-12 |
| Primary endpoint | Occurrence of Major Infections in Participants |
| Registry ID | NCT07220915 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:09.243Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07220915
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.